We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$161M
AUM Growth
+$11M
(+7.3%)
Cap. Flow
-$5.71M
Cap. Flow
% of AUM
-3.55%
Top 10 Holdings %
Top 10 Hldgs %
44.28%
Holding
361
New
80
Increased
31
Reduced
55
Closed
58
Avg Time Held Equity + Options
3.6
quarters
Top 10 Avg Time Held Equity + Options
2.1
quarters
Top 20 Avg Time Held Equity + Options
2.3
quarters
Avg Time Held Equity only
3.9
quarters
Top 10 Avg Time Held Equity only
3.5
quarters
Top 20 Avg Time Held Equity only
3.3
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Capri Holdings
CPRI
|
+$1.13M |
| 2 |
Biogen
BIIB
|
+$803K |
| 3 |
AbbVie
ABBV
|
+$773K |
| 4 |
MGM Resorts International
MGM
|
+$610K |
| 5 |
Kearny Financial
KRNY
|
+$521K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$1.79M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$1.34M |
| 3 |
General Motors Company
GM.WS.B
|
+$1.2M |
| 4 |
CELG
Celgene Corp
CELG
|
+$857K |
| 5 |
Taro Pharmaceutical Industries Ltd.
TARO
|
+$856K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.05% |
| 2 | Miscellaneous | 33% |
| 3 | Healthcare | 14.28% |
| 4 | Consumer Discretionary | 7.06% |
| 5 | Technology | 5.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
DELISTED
Kellanova
K
| $314K | 0.2% |
5,325
| – | – |
2014 Q4
2 quarters
|
|
|
DMND
102
DELISTED
DIAMOND FOODS, INC.
DMND
| $314K | 0.2% |
+10,000
| New | +$304K |
2015 Q2
0 quarters
|
|
|
BNCL
103
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $312K | 0.19% |
25,000
-10,000
| -29% | -$120K |
2015 Q1
1 quarter
|
|
104
DELISTED
Exact Sciences
EXAS
| $297K | 0.18% |
+10,000
| New | +$251K |
2015 Q2
0 quarters
|
|
|
QLIK
105
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
| $297K | 0.18% |
8,500
-6,500
| -43% | -$230K |
2014 Q4
2 quarters
|
|
106
Crocs
CROX
$5.6B
| $294K | 0.18% |
20,000
+10,000
| +100% | +$141K |
2015 Q1
1 quarter
|
|
107
Green Brick Partners
GRBK
$2.69B
| $293K | 0.18% |
26,739
+6,739
| +34% | +$62.4K |
2014 Q4
2 quarters
|
|
108
Incyte
INCY
$22.8B
| $292K | 0.18% |
2,800
| – | – |
2015 Q1
1 quarter
|
|
|
FNM
109
DELISTED
FANNIE MAE
FNM
| $291K | 0.18% |
125,000
+50,000
| +67% | +$116K |
2014 Q4
2 quarters
|
|
|
CELG
110
DELISTED
Celgene Corp
CELG
| $289K | 0.18% |
2,500
-7,500
| -75% | -$857K |
2015 Q1
1 quarter
|
|
|
111
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $287K | 0.18% |
2,000
-6,000
| -75% | -$856K |
2014 Q2
4 quarters
|
|
|
IPHI
112
DELISTED
INPHI CORPORATION
IPHI
| $286K | 0.18% |
12,500
-32,500
| -72% | -$722K |
2015 Q1
1 quarter
|
|
113
Beacon Financial Corp
BBT
$2.28B
| $285K | 0.18% |
10,000
| – | – |
2013 Q2
8 quarters
|
|
114
Lam Research
LRCX
$390B
| $285K | 0.18% |
+35,000
| New | +$275K |
2015 Q2
0 quarters
|
|
115
DELISTED
Real Industry, Inc.
RELY
| $284K | 0.18% |
+25,000
| New | +$260K |
2015 Q2
0 quarters
|
|
|
AERI
116
DELISTED
Aerie Pharmaceuticals
AERI
| $282K | 0.18% |
+16,000
| New | +$293K |
2015 Q2
0 quarters
|
|
117
YPF Sociedad Anonima ADS
YPF
$20.2B
| $274K | 0.17% |
+10,000
| New | +$292K |
2015 Q2
0 quarters
|
|
118
DELISTED
Kinder Morgan Inc
KMI.WS
| $270K | 0.17% |
100,000
| – | – |
2014 Q1
5 quarters
|
|
119
DELISTED
NEVRO CORP.
NVRO
| $269K | 0.17% |
5,000
-16,000
| -76% | -$815K |
2014 Q4
2 quarters
|
|
|
FWM
120
DELISTED
FAIRWAY GROUP HLDGS CORP CL A COM STK (DE)
FWM
| $268K | 0.17% |
75,190
| – | – |
2014 Q3
3 quarters
|
|
121
Ethan Allen Interiors
ETD
$515M
| $263K | 0.16% |
10,000
| – | – |
2015 Q1
1 quarter
|
|
122
Las Vegas Sands
LVS
$23.4B
| $263K | 0.16% |
5,000
| – | – |
2014 Q3
3 quarters
|
|
|
FRE.PRZ
123
DELISTED
FREDDIE MAC FIXED FLG RT NON CUM PERP PREF
FRE.PRZ
| $263K | 0.16% |
70,000
| – | – |
2013 Q2
8 quarters
|
|
124
DELISTED
Calavo Growers
CVGW
| $260K | 0.16% |
5,000
-2,500
| -33% | -$130K |
2013 Q2
8 quarters
|
|
125
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.94B
| $258K | 0.16% |
+5,000
| New | +$265K |
2015 Q2
0 quarters
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q2 2015 Portfolio in Review
As of Q2 2015, E.E. Geduld held 361 positions worth $161M, up 7.3% from $150M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
E.E. Geduld withdrew a net $5.71M in Q2 2015, closing 58 positions and reducing 55 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $1.79M position sold in full.
By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 33% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, E.E. Geduld opened a new position in Capri Holdings worth $842K.
- E.E. Geduld's largest Q2 2015 buy was Capri Holdings: 20,000 shares worth $842K.
- E.E. Geduld added most to Blackstone Mortgage Trust in Q2 2015, an estimated $355K increase.
- E.E. Geduld's biggest Q2 2015 reduction was Alnylam Pharmaceuticals, cutting an estimated $1.34M.
- E.E. Geduld fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $1.79M.
- E.E. Geduld's ten largest holdings make up 44% of its $161M portfolio in Q2 2015.
- E.E. Geduld opened 80 new positions and closed 58 in Q2 2015.
- E.E. Geduld's portfolio value rose 7.3% quarter-over-quarter to $161M.
Based on E.E. Geduld's 13F filing for Q2 2015, filed 7 Aug 2015.